The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of RAS and BRAF heterogeneity on the efficacy of EGFR blockade in patients with metastatic colorectal cancer.
 
Nobuhisa Matsuhashi
Honoraria - Abbott Japan; Alfresa Pharma Corporation; Amco; Asahi Kasei; AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Covidien; Daiichi Sankyo; EA Pharma; Eisai; Guardant Health; Gunze Medical; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Kyowa Kirin; Lilly Japan; MC Medical; Merck KGaA; Miyarisan pharmaceutical; MSD; Novartis; Olympus Marketing, Inc.; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Takeda; TERUMO; Tsumura & Co.; Viatris; Yakult Honsha; Zeria Pharmaceutical
Research Funding - Asahi Kasei (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); e-NA Biotec Inc. (Inst); Eisai (Inst); EPS Corporation (Inst); EPS Holdings (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Kyowa Kirin (Inst); MSD K.K (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Shift Zero (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst)
 
Takeshi Yamada
Research Funding - Taiho Pharmaceutical (Inst)
 
Takeshi Nagasaka
No Relationships to Disclose
 
Kozo Kataoka
Honoraria - Guardant Health; Lilly; Merck; Takeda
Research Funding - Nakatani Foundation; Sysmex
 
Kazuhiro Sakamoto
No Relationships to Disclose
 
Keiji Koda
Stock and Other Ownership Interests - Abbvie; Novo Nordisk
Speakers' Bureau - EA Pharma
 
Kazuhiro Hiramatsu
No Relationships to Disclose
 
Hiroshi Matsuoka
Speakers' Bureau - Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan
 
Hidekazu Kuramochi
No Relationships to Disclose
 
Hideyuki Ishida
No Relationships to Disclose
 
Hajime Yokomizo
No Relationships to Disclose
 
Yoshinori Kagawa
Consulting or Advisory Role - Lilly; Merck; Taiho Pharmaceutical; Takeda Science Foundation
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Ono Pharmaceutical
 
Mitsukuni Suenaga
Honoraria - Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Akihisa Matsuda
No Relationships to Disclose
 
Jun Nagata
No Relationships to Disclose
 
Kei Ishimaru
No Relationships to Disclose
 
Chihiro Kosugi
No Relationships to Disclose
 
Takao Takahashi
No Relationships to Disclose
 
Hiroshi Yoshida
No Relationships to Disclose
 
Keiji Hirata
No Relationships to Disclose